Sensei

Sensei Biotherapeutics Grants Stock Options to 17 New Employees, Including COO

Strategic Move to Attract and Retain Talent in the Biotech Sector What does it take to attract top talent in the highly competitive biotech industry? Sensei Biotherapeutics, Inc. a clinical-stage biotechnology company focused on developing next-generation therapeutics for cancer patients,…

Read MoreSensei Biotherapeutics Grants Stock Options to 17 New Employees, Including COO
Mevion Medical Systems

Mevion Medical Systems Receives CE Mark for World’s First LINAC Vault-Ready Proton Therapy System

Regulatory Milestone Enables European Expansion of Advanced Proton Therapy Why is proton therapy still out of reach for many European cancer centers? Mevion Medical Systems, the global leader in compact proton therapy, has announced that the MEVION S250-FIT Proton Therapy…

Read MoreMevion Medical Systems Receives CE Mark for World’s First LINAC Vault-Ready Proton Therapy System
Ascensia Diabetes Care

Ascensia Diabetes Care Appoints Peter Bodlund as CEO, Effective April 1, 2026

Leadership Transition Signals Ascensia’s Commitment to Long-Term Growth and Innovation Why is the leadership transition at Ascensia Diabetes Care significant for the global healthcare industry? Ascensia Diabetes Care, a global leader in diabetes management solutions, has announced the appointment of…

Read MoreAscensia Diabetes Care Appoints Peter Bodlund as CEO, Effective April 1, 2026
Ionis

Ionis Pharmaceuticals Reports Strong 2025 Financials and Pipeline Progress

Ionis Poised for Continued Growth with Multiple Upcoming Therapeutic Launches Is the biotech industry ready for a new wave of transformative therapies? Ionis Pharmaceuticals, a leader in RNA-targeted therapies, reported robust financial results and significant pipeline advancements for the year ended…

Read MoreIonis Pharmaceuticals Reports Strong 2025 Financials and Pipeline Progress
Kivu Bioscience

Kivu Bioscience Advances KIVU-305 into Clinical Trials for CEACAM5-Expressing Cancers

Kivu Bioscience Secures HREC Approval and CTN Clearance for Next-Generation ADC Why are next-generation antibody-drug conjugates (ADCs) crucial for advancing cancer treatments? Kivu Bioscience, a clinical-stage biotechnology company based in San Mateo, CA, is making significant strides in this area.…

Read MoreKivu Bioscience Advances KIVU-305 into Clinical Trials for CEACAM5-Expressing Cancers
Prothena

Verdiva Bio Completes Enrollment for Phase 2b EVOLVE-2 Study of VRB-101

Verdiva Bio Advances Obesity Therapy with Once-Weekly Oral GLP-1 Peptide Analog Is the pharmaceutical industry on the brink of a breakthrough in obesity treatment? Verdiva Bio Limited a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and cardiometabolic…

Read MoreVerdiva Bio Completes Enrollment for Phase 2b EVOLVE-2 Study of VRB-101
Alluvium

Alluvium Unveils AI-Powered Platform to Transform Health System Access and Capacity

Rebranding and New Platform Reflect Alluvium’s Commitment to Unified Data Management How can health systems navigate the complex challenges of capacity management and revenue optimization? Alluvium, formerly known as BlockIt, is addressing this critical issue with the launch of its…

Read MoreAlluvium Unveils AI-Powered Platform to Transform Health System Access and Capacity